Dear allstaters,
Imagine a cross-over trial with two periods. A patient was withdrawn during
period 1 after he took trial medication of that period. However, the same
patient appeared to all visits of period 2 without taking trial medication
of the second period. To which treatment this patient have to be assigned
for
1) efficacy analyis (are there differences between ITT and PP analysis?)
2) safety analysis?
Thanks in advance!
J. Weber
__________________________________________________________________
Tiscali DSL
Ihre Formel1 fürs Internet - faire Preise und coole Services
http://www.tiscali.de/main/internet/dslindex.html
|